NEJM March 2026: Volume 394, Issue 11 – Latest Research
A novel therapy, sotatercept, is demonstrating significant promise in the treatment of pulmonary arterial hypertension (PAH), a serious and progressive condition affecting the heart and lungs. Results from a recent clinical trial, published in the New England Journal of Medicine, suggest the drug can substantially improve exercise capacity and reduce the risk of clinical worsening … Read more